GTS Securities’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$210K Buy
+566
New +$200K ﹤0.01% 1517
2026
Q1
– Sell
-947
Closed -$261K – 1876
2025
Q4
$261K Sell
947
-3,671
-79% -$1M 0.01% 1134
2025
Q3
$1.21M Buy
+4,618
New +$1.12M 0.05% 337
2025
Q1
– Sell
-689
Closed -$226K – 1623
2024
Q4
$226K Sell
689
-1,156
-63% -$364K 0.01% 1042
2024
Q3
$554K Buy
+1,845
New +$565K ﹤0.01% 2721
2024
Q1
– Sell
-1,171
Closed -$412K – 4498
2023
Q4
$412K Buy
+1,171
New +$414K ﹤0.01% 2947

Other funds holding WST

GTS Securities's WST Position: Q3 2026 in Review

GTS Securities opened a new position in West Pharmaceutical (WST) in Q3 2026: 566 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings. This is a return to the name: GTS Securities previously reported a position in WST as recently as Q4 2025.

GTS Securities first reported a position in WST in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.21M in Q3 2025. 865 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • GTS Securities held 566 shares of West Pharmaceutical worth $210K as of Q3 2026.
  • West Pharmaceutical was a new GTS Securities position in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1517 holding.
  • GTS Securities first reported a position in West Pharmaceutical in Q4 2023 and has held it in 6 quarters since.
  • GTS Securities's West Pharmaceutical position peaked at $1.21M in Q3 2025.
  • 865 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.